Transcriptional regulation of osteoblasts

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 196-207

  Franceschi, Renny T ^a,d   Ge, Chunxi ^a   Xiao, Guozhi ^b   Roca, Hernan ^c   Jiang, Di ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone; Extracellular matrix; Osteoblast; RUNX2; Transcription

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SERINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CONFERENCE PAPER; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSGENE;

EID: 37249028142     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.081     Document Type: Conference Paper

References (28)

1. DUCY, P. et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments]. Cell 89: 747-754.
2. NAKASHIMA, K. et al. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
3. YANG, X. et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117: 387-398.
4. ZHOU, G. et al. 2006. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. USA 103: 19004-19009.
5. OTTO, F. et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
6. KOMORI, T. et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
7. XIAO, G. et al. 1998. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J. Biol. Chem. 273: 32988-32994.
8. ROCA, H. et al. 2005. Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene. J. Biol. Chem. 280: 30845-30855.
9. ITO, Y. 2004. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23: 4198-4208.
10. XIAO, G. et al. 2005. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280: 30689-30696.
11. JIANG, D. et al. 2004. Parathyroid hormone induction of the osteocalcin gene. Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple-signaling pathways. J. Biol. Chem. 279: 5329-5337.
12. AFZAL, F. et al. 2005. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell. Physiol. 204: 63-72.
13. BIALEK, P. et al. 2004. A twist code determines the onset of osteoblast differentiation. Dev. Cell. 6: 423-435.
14. IMAI, Y. et al. 2004. The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1. Mol. Cell Biol. 24: 1033-1043.
15. HYNES, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
16. YOU, J. et al. 2001. Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J. Biol. Chem. 276: 13365-13371.
17. ENGLER, A.J. et al. 2006. Matrix elasticity directs stem cell lineage specification [see comment]. Cell 126: 677-689.
18. FRANCESCHI, R.T. 1992. The role of ascorbic acid in mesenchymal differentiation. Nutr. Rev. 50: 65-70.
19. XIAO, G. et al. 1997. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol. Endocrinol. 11: 1103-1113.
20. XIAO, G. et al. 2000. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 275: 4453-4459.
21. FRENDO, J.L. et al. 1998. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J. Biol. Chem. 273: 30509-30516.
22. XIAO, G. et al. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 277: 36181-36187.
23. KIM, H.J. et al. 2003. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J. Biol. Chem. 278: 319-326.
24. WANG, F.S. et al. 2002. Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J. Biol. Chem. 277: 10931-10937.
25. ZIROS, P.G. et al. 2002. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J. Biol. Chem. 277: 23934-23941.
26. KANNO, T. et al. 2007. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J. Cell. Biochem. 101: 1266-1277.
27. GE, C. et al. 2007. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell. Biol. 176: 709-718.
28. FRANCESCHI, R.T. et al. 2003. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect. Tissue Res. 44(Suppl 1): 109-116.